Board to review September results and consider second interim dividend
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts more than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Board will meet on November 4, 2026, to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. It will also consider a second interim dividend for financial year 2026-27, if declared.
The meeting may bring earnings updates and a possible dividend, but no amount or financial details were disclosed.